2025-08-012026-07-312026-07-31false03591204NEUROLOGY ACADEMY LIMITED2026-09-0972200falseiso4217:GBPxbrli:pure035912042025-07-31035912042026-07-31035912042025-08-012026-07-31035912042024-07-31035912042025-07-31035912042024-08-012025-07-3103591204bus:SmallEntities2025-08-012026-07-3103591204bus:AuditExempt-NoAccountantsReport2025-08-012026-07-3103591204bus:FullAccounts2025-08-012026-07-3103591204bus:PrivateLimitedCompanyLtd2025-08-012026-07-3103591204core:WithinOneYear2026-07-3103591204core:AfterOneYear2026-07-3103591204core:WithinOneYear2025-07-3103591204core:AfterOneYear2025-07-3103591204core:ShareCapital2026-07-3103591204core:SharePremium2026-07-3103591204core:RevaluationReserve2026-07-3103591204core:OtherReservesSubtotal2026-07-3103591204core:RetainedEarningsAccumulatedLosses2026-07-3103591204core:ShareCapital2025-07-3103591204core:SharePremium2025-07-3103591204core:RevaluationReserve2025-07-3103591204core:OtherReservesSubtotal2025-07-3103591204core:RetainedEarningsAccumulatedLosses2025-07-3103591204core:LandBuildings2026-07-3103591204core:PlantMachinery2026-07-3103591204core:Vehicles2026-07-3103591204core:FurnitureFittings2026-07-3103591204core:OfficeEquipment2026-07-3103591204core:NetGoodwill2026-07-3103591204core:IntangibleAssetsOtherThanGoodwill2026-07-3103591204core:ListedExchangeTraded2026-07-3103591204core:UnlistedNon-exchangeTraded2026-07-3103591204core:LandBuildings2025-07-3103591204core:PlantMachinery2025-07-3103591204core:Vehicles2025-07-3103591204core:FurnitureFittings2025-07-3103591204core:OfficeEquipment2025-07-3103591204core:NetGoodwill2025-07-3103591204core:IntangibleAssetsOtherThanGoodwill2025-07-3103591204core:ListedExchangeTraded2025-07-3103591204core:UnlistedNon-exchangeTraded2025-07-3103591204core:LandBuildings2025-08-012026-07-3103591204core:PlantMachinery2025-08-012026-07-3103591204core:Vehicles2025-08-012026-07-3103591204core:FurnitureFittings2025-08-012026-07-3103591204core:OfficeEquipment2025-08-012026-07-3103591204core:NetGoodwill2025-08-012026-07-3103591204core:IntangibleAssetsOtherThanGoodwill2025-08-012026-07-3103591204core:ListedExchangeTraded2025-08-012026-07-3103591204core:UnlistedNon-exchangeTraded2025-08-012026-07-3103591204core:MoreThanFiveYears2025-08-012026-07-3103591204core:Non-currentFinancialInstruments2026-07-3103591204core:Non-currentFinancialInstruments2025-07-3103591204dpl:CostSales2025-08-012026-07-3103591204dpl:DistributionCosts2025-08-012026-07-3103591204core:LandBuildings2025-08-012026-07-3103591204core:PlantMachinery2025-08-012026-07-3103591204core:Vehicles2025-08-012026-07-3103591204core:FurnitureFittings2025-08-012026-07-3103591204core:OfficeEquipment2025-08-012026-07-3103591204dpl:AdministrativeExpenses2025-08-012026-07-3103591204core:NetGoodwill2025-08-012026-07-3103591204core:IntangibleAssetsOtherThanGoodwill2025-08-012026-07-3103591204dpl:GroupUndertakings2025-08-012026-07-3103591204dpl:ParticipatingInterests2025-08-012026-07-3103591204dpl:GroupUndertakingscore:ListedExchangeTraded2025-08-012026-07-3103591204core:ListedExchangeTraded2025-08-012026-07-3103591204dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-08-012026-07-3103591204core:UnlistedNon-exchangeTraded2025-08-012026-07-3103591204dpl:CostSales2024-08-012025-07-3103591204dpl:DistributionCosts2024-08-012025-07-3103591204core:LandBuildings2024-08-012025-07-3103591204core:PlantMachinery2024-08-012025-07-3103591204core:Vehicles2024-08-012025-07-3103591204core:FurnitureFittings2024-08-012025-07-3103591204core:OfficeEquipment2024-08-012025-07-3103591204dpl:AdministrativeExpenses2024-08-012025-07-3103591204core:NetGoodwill2024-08-012025-07-3103591204core:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3103591204dpl:GroupUndertakings2024-08-012025-07-3103591204dpl:ParticipatingInterests2024-08-012025-07-3103591204dpl:GroupUndertakingscore:ListedExchangeTraded2024-08-012025-07-3103591204core:ListedExchangeTraded2024-08-012025-07-3103591204dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-08-012025-07-3103591204core:UnlistedNon-exchangeTraded2024-08-012025-07-3103591204core:NetGoodwill2026-07-3103591204core:IntangibleAssetsOtherThanGoodwill2026-07-3103591204core:LandBuildings2026-07-3103591204core:PlantMachinery2026-07-3103591204core:Vehicles2026-07-3103591204core:FurnitureFittings2026-07-3103591204core:OfficeEquipment2026-07-3103591204core:AfterOneYear2026-07-3103591204core:WithinOneYear2026-07-3103591204core:ListedExchangeTraded2026-07-3103591204core:UnlistedNon-exchangeTraded2026-07-3103591204core:ShareCapital2026-07-3103591204core:SharePremium2026-07-3103591204core:RevaluationReserve2026-07-3103591204core:OtherReservesSubtotal2026-07-3103591204core:RetainedEarningsAccumulatedLosses2026-07-3103591204core:NetGoodwill2025-07-3103591204core:IntangibleAssetsOtherThanGoodwill2025-07-3103591204core:LandBuildings2025-07-3103591204core:PlantMachinery2025-07-3103591204core:Vehicles2025-07-3103591204core:FurnitureFittings2025-07-3103591204core:OfficeEquipment2025-07-3103591204core:AfterOneYear2025-07-3103591204core:WithinOneYear2025-07-3103591204core:ListedExchangeTraded2025-07-3103591204core:UnlistedNon-exchangeTraded2025-07-3103591204core:ShareCapital2025-07-3103591204core:SharePremium2025-07-3103591204core:RevaluationReserve2025-07-3103591204core:OtherReservesSubtotal2025-07-3103591204core:RetainedEarningsAccumulatedLosses2025-07-3103591204core:NetGoodwill2024-07-3103591204core:IntangibleAssetsOtherThanGoodwill2024-07-3103591204core:LandBuildings2024-07-3103591204core:PlantMachinery2024-07-3103591204core:Vehicles2024-07-3103591204core:FurnitureFittings2024-07-3103591204core:OfficeEquipment2024-07-3103591204core:AfterOneYear2024-07-3103591204core:WithinOneYear2024-07-3103591204core:ListedExchangeTraded2024-07-3103591204core:UnlistedNon-exchangeTraded2024-07-3103591204core:ShareCapital2024-07-3103591204core:SharePremium2024-07-3103591204core:RevaluationReserve2024-07-3103591204core:OtherReservesSubtotal2024-07-3103591204core:RetainedEarningsAccumulatedLosses2024-07-3103591204core:AfterOneYear2025-08-012026-07-3103591204core:WithinOneYear2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:CostValuation2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-012026-07-3103591204core:Non-currentFinancialInstrumentscore:CostValuation2026-07-3103591204core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-07-3103591204core:Non-currentFinancialInstrumentscore:CostValuation2025-07-3103591204core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-07-3103591204core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-07-3103591204core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-07-3103591204core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-07-3103591204core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-07-3103591204core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-07-3103591204core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-07-3103591204core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-07-3103591204bus:Director12025-08-012026-07-31035912041bus:Director12025-07-31035912041bus:Director12025-08-012026-07-31035912041bus:Director12026-07-31035912042025-07-31035912042025-08-012026-07-31035912042026-07-31

NEUROLOGY ACADEMY LIMITED

Registered Number
03591204
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2026

NEUROLOGY ACADEMY LIMITED
Company Information
for the year from 1 August 2025 to 31 July 2026

Director

Sarah J GILLETT

Company Secretary

GILLETT, Maisy Jane

Registered Address

St Deny's House
22 East Hill
St. Austell
PL25 4TR

Registered Number

03591204 (England and Wales)
NEUROLOGY ACADEMY LIMITED
Balance Sheet as at
31 July 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets337,52454,154
37,52454,154
Current assets
Stocks42,0002,000
Debtors5217,327228,834
Cash at bank and on hand305,917166,561
525,244397,395
Creditors amounts falling due within one year6(500,225)(413,758)
Net current assets (liabilities)25,019(16,363)
Total assets less current liabilities62,54337,791
Creditors amounts falling due after one year7(28,621)-
Provisions for liabilities8(9,380)(13,538)
Net assets24,54224,253
Capital and reserves
Called up share capital55
Profit and loss account24,53724,248
Shareholders' funds24,54224,253
The financial statements were approved and authorised for issue by the Director on 9 September 2026, and are signed on its behalf by:
Sarah J GILLETT
Director
Registered Company No. 03591204
NEUROLOGY ACADEMY LIMITED
Notes to the Financial Statements
for the year ended 31 July 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Plant and machinery7
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20262025
Average number of employees during the year1416
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 August 25171,857171,857
Additions1,6821,682
At 31 July 26173,539173,539
Depreciation and impairment
At 01 August 25117,703117,703
Charge for year18,31218,312
At 31 July 26136,015136,015
Net book value
At 31 July 2637,52437,524
At 31 July 2554,15454,154
4.Stocks

2026

2025

££
Raw materials and consumables2,0002,000
Total2,0002,000
5.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables205,866189,435
Other debtors-7,953
Prepayments and accrued income11,46131,446
Total217,327228,834
6.Creditors: amounts due within one year

2026

2025

££
Bank borrowings and overdrafts19,414-
Taxation and social security94,46474,788
Other creditors30,06275,052
Accrued liabilities and deferred income356,285263,918
Total500,225413,758
7.Creditors: amounts due after one year

2026

2025

££
Bank borrowings and overdrafts28,621-
Total28,621-
8.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)9,38013,538
Total9,38013,538
9.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Sarah J GILLETT024,062024,062
024,062024,062
10.Related party transactions
During the year the shareholder Maisy Gillett, the daughter of the director Sarah Gillett, received a dividend of £6,000 in accordance with the dividend declared on the company's ordinary shares.